Seeding Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24)

The summary for the Seeding Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Seeding Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24)
	CFDA Number:	93.847
	CFDA Description:	Diabetes, Endocrinology and Metabolism Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Food and Nutrition Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-08-181
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Dec 03, 2008
	Creation Date:	Dec 03, 2008
	Original Closing Date for Applications:	Sep 07, 2011
	Current Closing Date for Applications:	Sep 07, 2011
	Archive Date:	Oct 08, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) .
Grant Description: -Purpose. The purpose of the Seeding Collaborative Interdisciplinary Team Science Program described in this announcement is to provide initial support to enable strong new investigative teams to form, and to foster preliminary research activities.It is anticipated that research teams receiving seeding support under this program will be well positioned to compete for funds through the parent NIDDK Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases solicitation (see PAR-08-182). -Mechanism of Support. This FOA will utilize the Resource Research (R24) grant mechanism. -Funds Available and Anticipated Number of Awards. It is anticipated that 5-10 projects will be funded, but because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-08-181.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Pediatric Centers of Excellence in Nephrology (P50); • Nutrition Obesity Research Centers (P30); • George M. OBrien Kidney Research Core Centers (P30); • Cooperative Study Group for Autoimmune Disease Prevention (U01); • Collaborative Interdisciplinary Team Science in NIDDK Research Areas (R24); • PROTEOMIC AND METABOLOMIC APPROACHES TO DIAGNOSE DIABETES AND PRE-DIABETES; • MOLECULAR THERAPY CORE CENTERS; • PILOT AND FEASIBILITY PROGRAM IN HUMAN ISLET BIOLOGY; • DIABETES ENDOCRINOLOGY RESEARCH CENTERS; • CYSTIC FIBROSIS RESEARCH AND TRANSLATION CORE CENTERS